Aspirin/meprobamate

Aspirin/meprobamate (trade name Equagesic /ˌɛkwəˈdʒiːzɪk/) is a combination drug indicated for short-term pain treatment accompanied by tension or anxiety in patients with musculoskeletal disorders or tension headache.

Aspirin/meprobamate

Combination of
Aspirin	NSAID
Meprobamate	Anxiolytic
Clinical data
Trade names	Equagesic
AHFS/Drugs.com	Micromedex Detailed Consumer Information
Routes of administration	Oral
ATC code	N05BC51 (WHO)
Legal status
Legal status	US: ℞-only
Identifiers
CAS Number	8056-21-1

Adverse effects

See also: Aspirin § Adverse effects, and Meprobamate § Adverse effects

Combinations

There also appears to be a combination with ethoheptazine, an opioid analgesic.^[1]

Problems

Equagesic was discontinued in the United States, because of its possible toxic effects, specifically of meprobamate.^{[2][medical citation needed]} It was credited with the sudden death of actor Bruce Lee in 1973. Lee suffered a fatal hypersensitive reaction to one of the prescription drug's ingredients while working in Hong Kong.^[3][4]